JEADV:Gottron丘疹和其他累及手背的炎症性皮肤病的皮肤镜检查

2022-03-19 医路坦 MedSci原创

皮肌炎(DM)是一种结缔组织疾病,以多种皮肤症状为特征,包括Gottron丘疹,日光征,本文目的描述Gottron丘疹的皮肤镜检查结果,并与其他累及手背的皮肤病的皮肤镜检查结果进行比较。

     皮肌炎(DM)是一种结缔组织疾病,以多种皮肤症状为特征,包括Gottron丘疹(指间和掌指关节上的红斑),日光征(眼眶周围区域的紫罗兰红斑),Gottron征(膝盖和肘关节上的紫罗兰红斑),V颈征(上胸区红斑),“披肩征”(上背部红斑),“皮套征”(大腿外侧红斑),甲皱病变,“机械手”和头皮病变。皮肤损害甚至可能早于肌炎的症状好几年,因此,识别具有特征性的皮肤表现可能会促使DM的早期诊断和优化治疗。

    Gottron丘疹被认为是DM最典型的皮肤症状之一。然而,其他几种炎症性皮肤病的临床表现可能是手背和关节上出现红斑丘疹或斑块。这些皮肤病的常见例子包括银屑病和慢性皮炎(CD)。此外,手上的红斑可能在其他实体中较少观察到,包括但不限于真菌样肉芽肿(Mf)、扁平苔藓(Lp)和毛发红斑(Prp)。

    在经典病例中,患者的病史和临床表现允许快速准确的诊断,特别是当典型病变出现在手以外的其他位置时。然而,在皮肤受累有限的早期阶段,制定正确的手部丘疹和斑块的鉴别诊断可能是具有挑战性的。在诊断不确定的情况下,组织病理学检查和额外的实验室检查是有帮助的。尽管如此,在经常活动的地方进行皮肤活检可能会影响患者的日常活动。

    皮肤镜是一种非侵入性的皮肤成像技术,越来越多地被用作皮肤肿瘤学以外的有价值的诊断工具,用于鉴别诊断炎症性皮肤状况。皮肤镜使供应商能够以更高的放大倍数获得图像,这反过来又有助于增强血管形态的可视化。这种特性在非肿瘤性皮肤病的评估中特别有用。

    本研究的目的是分析Gottron丘疹的皮肤镜特征,并将其与其他炎症性皮肤疾病(包括银屑病、CD、MF、LP和PRP)的皮肤镜检查结果进行比较,这些疾病可能涉及手背。

     皮肤镜检查包括DM12例,银屑病19例,慢性皮炎16例,真菌样肉芽肿7例,扁平苔藓5例,毛发红斑3例。66.7%的Gottron丘疹呈多形性血管(点状血管伴粗、细线状分支血管或线形弯曲血管),排列不清(91.7%),伴有白色或粉红色的无结构区(75.0%)。银屑病斑块以斑点状血管排列为特征(94.7%)。血管呈环状排列在银屑病中几乎是独有的,而黄色无结构区域和侵蚀在慢性皮炎中更常见。对应于Wickham条纹的白色线条是扁平苔藓所特有的。

     皮肤镜在鉴别Gottron丘疹和其他涉及手背的皮肤病方面可能有价值。

图1 (A)手关节背侧Gottron丘疹-临床表现;(b,c,d)视频皮肤镜显示粗细的线状血管,有分支(黑色箭头),伴有虚线血管(白色箭头),白色无结构区域,无可见血管(黑色星号)和单个角化栓子(蓝色箭头)。

图2 (A)手关节背部银屑病丘疹-临床表现;(b,c,d)视频皮肤镜显示均匀分布的点状/肾小球血管(黑色箭头),伴有斑片状白色鳞片(蓝色箭头);(C)皮肤镜下常见红色出血点(黑色星号)(D)球状血管呈环状排列(黄色圆圈)。

图3 (A)慢性皮炎累及手部临床表现;(b,c)视频皮肤镜显示分布不明的点状血管(黑色箭头)、小侵蚀(蓝色箭头)和红色出血点(白色箭头);也可观察到离散的白色鳞片(黑色星号)

图4 (A)累及手部临床表现背部的真菌病;(B)视频皮肤镜显示不明分布的点状血管(黑色箭头)和单个线状弯曲血管(白色箭头),出血点(蓝色箭头)和黄色斑片状鳞片(黑色星号)

图5 (A)累及手部背部的扁平苔藓;(b,c)视频皮肤镜显示周围(B)或未指明(C)分布的虚线状血管(黑色箭头)和线形弯曲血管(蓝色箭头),白色斑片状鳞片(黄色圆圈),白色无结构区域(黑色星号)和对应Wickham条纹的白色线条(蓝色星号)

图6(a) 涉及手背的糠疹-糠疹-临床表现;(b) 电视皮肤镜检查显示点状血管(黑色箭头)分布均匀,白色斑片状鳞片(黑色星号)

文献来源:Żychowska M,  Łudzik J,  Witkowski A,Dermoscopy of Gottron's papules and other inflammatory dermatoses involving the dorsa of the hands.J Eur Acad Dermatol Venereol 2022 Mar 11;

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1972284, encodeId=71aa19e228441, content=<a href='/topic/show?id=2b731e914ad' target=_blank style='color:#2F92EE;'>#TTR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17914, encryptionId=2b731e914ad, topicName=TTR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Wed Nov 02 10:33:53 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826163, encodeId=1ce118261635f, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Aug 19 17:33:53 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784961, encodeId=ea661e84961c2, content=<a href='/topic/show?id=f94e64211a' target=_blank style='color:#2F92EE;'>#EADV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6421, encryptionId=f94e64211a, topicName=EADV)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Mon Jun 20 07:33:53 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480750, encodeId=bfe21480e509a, content=<a href='/topic/show?id=0bc3208e417' target=_blank style='color:#2F92EE;'>#丘疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20874, encryptionId=0bc3208e417, topicName=丘疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26147676061, createdName=ms7517674339485982, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486662, encodeId=b4cd148666276, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547530, encodeId=4e44154e53072, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
    2022-11-02 pps20019
  2. [GetPortalCommentsPageByObjectIdResponse(id=1972284, encodeId=71aa19e228441, content=<a href='/topic/show?id=2b731e914ad' target=_blank style='color:#2F92EE;'>#TTR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17914, encryptionId=2b731e914ad, topicName=TTR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Wed Nov 02 10:33:53 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826163, encodeId=1ce118261635f, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Aug 19 17:33:53 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784961, encodeId=ea661e84961c2, content=<a href='/topic/show?id=f94e64211a' target=_blank style='color:#2F92EE;'>#EADV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6421, encryptionId=f94e64211a, topicName=EADV)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Mon Jun 20 07:33:53 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480750, encodeId=bfe21480e509a, content=<a href='/topic/show?id=0bc3208e417' target=_blank style='color:#2F92EE;'>#丘疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20874, encryptionId=0bc3208e417, topicName=丘疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26147676061, createdName=ms7517674339485982, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486662, encodeId=b4cd148666276, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547530, encodeId=4e44154e53072, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1972284, encodeId=71aa19e228441, content=<a href='/topic/show?id=2b731e914ad' target=_blank style='color:#2F92EE;'>#TTR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17914, encryptionId=2b731e914ad, topicName=TTR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Wed Nov 02 10:33:53 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826163, encodeId=1ce118261635f, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Aug 19 17:33:53 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784961, encodeId=ea661e84961c2, content=<a href='/topic/show?id=f94e64211a' target=_blank style='color:#2F92EE;'>#EADV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6421, encryptionId=f94e64211a, topicName=EADV)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Mon Jun 20 07:33:53 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480750, encodeId=bfe21480e509a, content=<a href='/topic/show?id=0bc3208e417' target=_blank style='color:#2F92EE;'>#丘疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20874, encryptionId=0bc3208e417, topicName=丘疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26147676061, createdName=ms7517674339485982, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486662, encodeId=b4cd148666276, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547530, encodeId=4e44154e53072, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1972284, encodeId=71aa19e228441, content=<a href='/topic/show?id=2b731e914ad' target=_blank style='color:#2F92EE;'>#TTR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17914, encryptionId=2b731e914ad, topicName=TTR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Wed Nov 02 10:33:53 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826163, encodeId=1ce118261635f, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Aug 19 17:33:53 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784961, encodeId=ea661e84961c2, content=<a href='/topic/show?id=f94e64211a' target=_blank style='color:#2F92EE;'>#EADV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6421, encryptionId=f94e64211a, topicName=EADV)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Mon Jun 20 07:33:53 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480750, encodeId=bfe21480e509a, content=<a href='/topic/show?id=0bc3208e417' target=_blank style='color:#2F92EE;'>#丘疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20874, encryptionId=0bc3208e417, topicName=丘疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26147676061, createdName=ms7517674339485982, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486662, encodeId=b4cd148666276, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547530, encodeId=4e44154e53072, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1972284, encodeId=71aa19e228441, content=<a href='/topic/show?id=2b731e914ad' target=_blank style='color:#2F92EE;'>#TTR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17914, encryptionId=2b731e914ad, topicName=TTR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Wed Nov 02 10:33:53 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826163, encodeId=1ce118261635f, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Aug 19 17:33:53 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784961, encodeId=ea661e84961c2, content=<a href='/topic/show?id=f94e64211a' target=_blank style='color:#2F92EE;'>#EADV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6421, encryptionId=f94e64211a, topicName=EADV)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Mon Jun 20 07:33:53 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480750, encodeId=bfe21480e509a, content=<a href='/topic/show?id=0bc3208e417' target=_blank style='color:#2F92EE;'>#丘疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20874, encryptionId=0bc3208e417, topicName=丘疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26147676061, createdName=ms7517674339485982, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486662, encodeId=b4cd148666276, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547530, encodeId=4e44154e53072, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1972284, encodeId=71aa19e228441, content=<a href='/topic/show?id=2b731e914ad' target=_blank style='color:#2F92EE;'>#TTR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17914, encryptionId=2b731e914ad, topicName=TTR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Wed Nov 02 10:33:53 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826163, encodeId=1ce118261635f, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Aug 19 17:33:53 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784961, encodeId=ea661e84961c2, content=<a href='/topic/show?id=f94e64211a' target=_blank style='color:#2F92EE;'>#EADV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6421, encryptionId=f94e64211a, topicName=EADV)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Mon Jun 20 07:33:53 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480750, encodeId=bfe21480e509a, content=<a href='/topic/show?id=0bc3208e417' target=_blank style='color:#2F92EE;'>#丘疹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20874, encryptionId=0bc3208e417, topicName=丘疹)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26147676061, createdName=ms7517674339485982, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486662, encodeId=b4cd148666276, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547530, encodeId=4e44154e53072, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Mon Mar 21 07:33:53 CST 2022, time=2022-03-21, status=1, ipAttribution=)]

相关资讯

Neurology:皮肌炎:不同抗体分类潜在亚型的潜在病理生物学机制不同

近日,有研究人员探究了MXA阳性 皮肌炎的肌病理特征,以确定不同DMSA亚型的肌病理特征。在该研究中,DMSA与不同的肌肉病理特征相关,提示每种亚型的潜在病理生物学机制不同。

入住重症监护病房 (ICU) 的结缔组织疾病患者的脓毒症死亡率很高

系统性红斑狼疮 (SLE) 等结缔组织疾病 (CTD) 患者感染的风险增加。本研究调查了在重症监护室 (ICU) 治疗脓毒症的 CTD 患者的结果和特征。

JAMA Dermatol:Secukinumab治疗与银屑病患者皮肌炎恶化的关系

Suckinumab是一种针对并中和白细胞介素(IL)17A的人类单克隆抗体。使用seckinumab治疗与免疫相关的不良反应。本文报告了首例银屑病患者的抗IL-17A相关皮肌炎(DM)加重病例。

J Dermatol:阿普利司特可有效治疗难治性和复发性皮肌炎相关皮损

皮肌炎是一种特发性炎症性肌病,以皮肤瘙痒表现为特征,即使经过强化免疫抑制治疗,也常难以治愈,并常表现为复发性。

让一个人接受死亡需要多久?认识抗MDA5阳性皮肌炎伴快速进展型肺间质病变

“判定一个清醒的年轻女性必将死亡,需要多久?让一个人接受死亡,需要多久?”。对于一个“MDA5阳性皮肌炎伴快速进展型肺间质病变”的患者来说可能只需要3天。

关于皮肌炎的21个问题,建议收藏!

皮肌炎属自身免疫性疾病,主要累及横纹肌,可伴有红斑水肿等多种皮肤损害,常伴发关节、心肌等多器官损害,以亚急性和慢性发病为主。